Cited by 110Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products researchLiver physiology and pathology

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis

Open access

Gaens, Katrien H.J., Niessen, Petra M.G., Rensen, Sander S., Buurman, Wim A., Greve, Jan Willem M., Driessen, Ann, Wolfs, Marcel G.M., Hofker, Marten H., Bloemen, Johanne G., Dejong, Cornelis H., Stehouwer, Coen D.A., Schalkwijk, Casper G.·2012·Journal of Hepatology

DOI 10.1016/j.jhep.2011.07.028

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Increased lipid peroxidation and inflammation are major factors in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). A lipoxidation product that could play a role in the induction of hepatic inflammation is N(ε)-(carboxymethyl)lysine (CML). The aim of the present study was to investigate the relationship between steatosis and CML and to study the role of CML in hepatic inflammation.Methods We included 74 obese individuals, which were categorized into 3 groups according to the grade of hepatic steatosis. CML accumulation in liver biopsies was assessed by immunohistochemistry and plasma CML levels were measured by mass spectrometry. Plasma CML levels were also determined in the hepatic artery, portal, and hepatic vein of 22 individuals, and CML fluxes across the liver were calculated. Hepatocyte cell lines were used to study CML formation during intracellular lipid accumulation and the effect of CML on pro-inflammatory cytokine expression. Gene expression levels of the inflammatory markers were determined in liver biopsies of the obese individuals.Results CML accumulation was significantly associated with the grade of hepatic steatosis, the grade of hepatic inflammation, and gene expression levels of inflammatory markers PAI-1, IL-8, and CRP. Analysis of CML fluxes showed no release/uptake of CML by the liver. Lipid accumulation in hepatocytes, induced by incubation with fatty acids, was associated with increased CML formation and expression of the receptor for advanced glycation endproducts (RAGE), PAI-1, IL-8, IL-6, and CRP. Pyridoxamine and aminoguanidine inhibited the endogenous CML formation and the increased RAGE, PAI-1, IL-8, IL-6, and CRP expression. Incubation of hepatocytes with CML-albumin increased the expression of RAGE, PAI-1, and IL-6, which was inhibited by an antibody against RAGE.Conclusions Accumulation of CML and a CML-upregulated RAGE-dependent inflammatory response in steatotic livers may play an important role in hepatic steatosis and in the pathogenesis of NAFLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2011.07.028

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868
The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Fatty Liver
Kotronen, A., & Yki‐Järvinen, H. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 793
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 605
Short chain fatty acids exchange across the gut and liver in humans measured at surgery
Bloemen, J. G., Venema, K., van de Poll, M. C., Olde Damink, S. W., Buurman, W. A., & Dejong, C. H. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.05.011 · Cited by 382
Self-citation
The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349

Show all 36 references

Sorted by citations

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.
van Greevenbroek, M. M. J., Schalkwijk, C., & Stehouwer, C. D. A. (2013) · PubMed · Cited by 233
Self-citation
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis
Polimeni, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i10.1325 · Cited by 213
N ε -(Carboxymethyl)lysine-Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance
Gaens, K. H. J., Goossens, G. H., Niessen, P., van Greevenbroek, M. M. J., Kallen, C., Niessen, H. W. M., Rensen, S. S., Buurman, W. A., Greve, J. W. M., Blaak, E. E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302281 · Cited by 196
Self-citation
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835aea13 · Cited by 166
Self-citation
Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation
Delgado‐Andrade, C. (2015) · Food & Function · doi:10.1039/c5fo00918a · Cited by 162
Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
Bijnen, M., Josefs, T., Cuijpers, I., Maalsen, C. J., van de Gaar, J., Vroomen, M., Wijnands, E., Rensen, S. S., Greve, J. W. M., Hofker, M. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313654 · Cited by 134
Self-citation
Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)
Yuan, Y., Sun, H. Q., & Sun, Z. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0522-6 · Cited by 108
Glyoxalase 1 Modulation in Obesity and Diabetes
Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102
Impact of obesity and overweight on DNA stability: Few facts and many hypotheses
Setayesh, T., Nersesyan, A., Mišík, M., Ferk, F., Langie, S., Andrade, V. M., Haslberger, A., & Knasmüller, S. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.07.001 · Cited by 98
The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome
Guo, W. A., Knight, P. R., & Raghavendran, K. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2624-y · Cited by 98
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 99
Advanced Glycation End Products in Disease Development and Potential Interventions
Zhang, Y., Zhang, Z., Tu, C., Chen, X., & He, R. (2025) · Antioxidants · doi:10.3390/antiox14040492 · Cited by 117
Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises
Matafome, P. N., Rodrigues, T., Sena, C. M., & Seiça, R. M. F. (2016) · Medicinal Research Reviews · doi:10.1002/med.21410 · Cited by 92
Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults
Palma-Duran, S. A., Kontogianni, M. D., Vlassopoulos, A., Zhao, S., Margariti, A., Georgoulis, M., Papatheodoridis, G., & Combet, E. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.023 · Cited by 87
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
Wetzels, S., Wouters, K., Schalkwijk, C. G., Vanmierlo, T., & Hendriks, J. J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020421 · Cited by 80
Self-citation
Development of Nonalcoholic Hepatopathy: Contributions of Oxidative Stress and Advanced Glycation End Products
Santos, J. C., Valentim, I. B., de Araújo, O. R. P., Ataíde, T. D. R., & Goulart, M. O. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019846 · Cited by 77
Role of receptor for advanced glycation end products (RAGE) in liver disease
Yamagishi, S., & Matsui, T. (2015) · European journal of medical research · doi:10.1186/s40001-015-0090-z · Cited by 76
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice
Mastrocola, R., Nigro, D., Chiazza, F., Medana, C., Bello, F. D., Boccuzzi, G., Collino, M., & Aragno, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.022 · Cited by 76
Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
Pereira, E. N. G. D. S., Silvares, R. R., Flores, E. E. I., Rodrigues, K. L., Ramos, I. P., da Silva, I. J., Pelajo‐Machado, M., Miranda, R. A., Pazos-Moura, C. C., Gonçalves-de-Albuquerque, C. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179654 · Cited by 66
Review article: fructose in non‐alcoholic fatty liver disease
Yilmaz, Y. N. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05080.x · Cited by 65
Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice
Mastrocola, R., Collino, M., Rogazzo, M., Medana, C., Nigro, D., Boccuzzi, G., & Aragno, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2012 · Cited by 63
The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC)
Hollenbach, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112466 · Cited by 62
RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
Asadipooya, K., Lankarani, K. B., Raj, R., & Kalantarhormozi, M. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2151302 · Cited by 63
Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes
Strieder‐Barboza, C., Baker, N. A., Flesher, C. G., Karmakar, M., Neeley, C. K., Polsinelli, D., Dimick, J. B., Finks, J. F., Ghaferi, A. A., Varban, O. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56242-z · Cited by 58
Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP‐1c in L‐02 Cells
Qin, S., Yin, J., & Huang, K. (2016) · Lipids · doi:10.1007/s11745-016-4160-y · Cited by 47
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Liu, Y., Mu, D., Chen, H., Li, D., Song, J., Yuan, Ž., & Xia, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1320 · Cited by 44
Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents
Alizadeh, M., & Kheirouri, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1396200 · Cited by 44
Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress
Pereira, E. N. G. D. S., de Araujo, B. P., Rodrigues, K. L., Silvares, R. R., Martins, C. S. M., Flores, E. E. I., Fernandes‐Santos, C., & Daliry, A. (2022) · Nutrients · doi:10.3390/nu14030716 · Cited by 43
Protein-Bound Plasma N ε -(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity–Related Increase in Inflammation
Gaens, K. H. J., Ferreira, I., van de Waarenburg, M. P. H., van Greevenbroek, M. M. J., Kallen, C., Dekker, J. M., Nijpels, G., Rensen, S. S., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306106 · Cited by 43
Self-citation
Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease
Trejo, A. M. C., Větvička, V., Vištějnová, L., Králíčková, M., & Montúfar, E. B. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1887730 · Cited by 41
An insight on the association of glycation with hepatocellular carcinoma
Jabir, N. R., Ahmad, S., & Tabrez, S. S. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.005 · Cited by 36
Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen
Sakiyama, H., Fujiwara, N., 米岡由佳, Yoshihara, D., Eguchi, H., & Suzuki, K. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1164856 · Cited by 35
Neutrophil‐derived advanced glycation end products‐Nε‐(carboxymethyl) lysine promotes RIP3‐mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury
Yang, J., Zhang, F., Shi, H., Gao, Y., Dong, Z., Ma, L., Sun, X., Li, X., Chang, S., Wang, Z., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900115rr · Cited by 34
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome
Santilli, F., Blardi, P., Scapellato, C., Bocchia, M., Guazzi, G., Terzuoli, L., Tabucchi, A., Silvietti, A., Lucani, B., Gioffrè, W. R., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.04.004 · Cited by 34
Molecular mechanism and therapeutic significance of essential amino acids in metabolically associated fatty liver disease
Deng, Y., Hu, M., Huang, S., & Fu, N. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109581 · Cited by 34
Immunometabolism and the modulation of immune responses and host defense: A role for methylglyoxal?
Zhang, X., Schalkwijk, C. G., & Wouters, K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166425 · Cited by 31
Self-citation
Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β
dos Santos, J. C. F., de Araújo, O. R. P., Valentim, I. B., de Andrade, K. Q., Moura, F. A., Smaniotto, S., dos Santos, J. M., Gasparotto, J., Gelain, D. P., & Goulart, M. O. F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/121925 · Cited by 30
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
Spanos, C., Maldonado, E. M., Fisher, C., Leenutaphong, P., Oviedo‐Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C. A., et al. (2018) · Proteome Science · doi:10.1186/s12953-018-0131-y · Cited by 31
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
Pereira, E. N. G. D. S., Paula, D. P., de Araujo, B. P., da Fonseca, M. D. J. M., Diniz, M. D. F. H. S., Daliry, A., & Griep, R. H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4913 · Cited by 27
Advanced Glycation End Products As Biomarkers in Systemic Diseases: Premises and Perspectives of Salivary Advanced Glycation End Products
Băbțan, A.-M., Ilea, A., Boşca, A. B., Crişan, M., Petrescu, N. B., Collino, M., Sainz, R. M., Gerlach, J. Q., & Câmpian, R. S. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0448 · Cited by 29
Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Roy, D., Ramasamy, R., & Schmidt, A. M. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315527 · Cited by 29
Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese
Cho, K., Nam, H.-S., Baek, S.-H., Kang, D.-J., Na, H., Komatsu, T., & Uehara, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065185 · Cited by 26
The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study
Meertens, J. H. J. M., Nienhuis, H. L. A., Lefrandt, J. D., Schalkwijk, C. G., Nyyssönen, K., Ligtenberg, J. J. M., Smit, A. J., Zijlstra, J. G., & Mulder, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160893 · Cited by 27
Self-citation
Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review
Lădaru, A., Balanescu, P. C., Stan, M., Codreanu, I. F., & Anca, I. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118542 · Cited by 26
Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis
Knani, I., Bouzidi, H., Zrour, S., Bergaoui, N., Hammami, M., & Kerkeni, M. (2018) · Disease Markers · doi:10.1155/2018/8735926 · Cited by 25
Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation
Cha, S., Hwang, Y., Heo, S., & Jun, H. (2019) · Marine Drugs · doi:10.3390/md17090486 · Cited by 25
Similarities and interactions between the ageing process and high chronic intake of added sugars
Gatineau, E., Polakof, S., Dardevet, D. P., & Mosoni, L. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000051 · Cited by 27
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
Garza-Campos, A., Prieto-Correa, J. R., Domínguez-Rosales, J. A., & Nazará, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.977 · Cited by 27
Binding of CML-Modified as Well as Heat-Glycated β-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity
Zenker, H. E., Teodorowicz, M., Ewaz, A., van Neerven, R. J. J., Savelkoul, H. F. J., de Jong, N. W., Wichers, H. J., & Hettinga, K. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124567 · Cited by 24
Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
Arivazhagan, L., López‐Díez, R., Shekhtman, A. G., Ramasamy, R., & Schmidt, A. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.937071 · Cited by 24
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr−/− mice
Bijnen, M., Beelen, N. A., Wetzels, S., van de Gaar, J., Vroomen, M. A. M., Wijnands, E., Scheijen, J. L. J. M., van de Waarenburg, M. P. H., Gijbels, M. J., Cleutjens, J. P. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33661-y · Cited by 23
Self-citation
Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
Bijnen, M., Josefs, T., Cuijpers, I., van de Gaar, J., Vroomen, M. A. M., Wijnands, E., Rensen, S. S., Greve, J. W. M., Hofker, M. H., Biessen, E. A. L., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31630-6 · Cited by 22
Self-citation
Synthesis and molecular docking studies of 5-acetyl-2-(arylidenehydrazin-1-yl)-4-methyl-1,3-thiazoles as α-amylase inhibitors
Mehmood, H., Haroon, M., Akhtar, T., Woodward, S., & Andleeb, H. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131807 · Cited by 22
In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model
Stellavato, A., Pirozzi, A. V. A., de Novellis, F., Scognamiglio, I., Vassallo, V., Giori, A. M., ROSA, M. D., & Schiraldi, C. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0663-2 · Cited by 21
Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease
Pereira, E. N. G. D. S., Silvares, R. R., Flores, E. E. I., Rodrigues, K. L., & Daliry, A. (2019) · Microcirculation · doi:10.1111/micc.12603 · Cited by 21
Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women
Sabrina, N., Bai, C., Chang, C., Chien, Y., Chen, J., & Chang, J. (2017) · Nutrients · doi:10.3390/nu9080833 · Cited by 21
From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage
Zhong, H., Gui, X., Hou, L., Lv, R., & Jin, Y. (2022) · Pathogens · doi:10.3390/pathogens11030289 · Cited by 20
Digestibility of Malondialdehyde-Induced Dietary Advanced Lipoxidation End Products and Their Effects on Hepatic Lipid Accumulation in Mice
Wang, Y., Zhang, T., Nie, L., Zhang, Y., Wang, J., Liu, Q., Dong, L., Hu, Y., Zhang, B., & Wang, S. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01956 · Cited by 20
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts
Mastrocola, R., Bello, F. D., Cento, A. S., Gaens, K. H. J., Collotta, D., Aragno, M., Medana, C., Collino, M., Wouters, K., & Schalkwijk, C. G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.028 · Cited by 20
Self-citation
Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
Bijnen, M., van Greevenbroek, M. M. J., Kallen, C., Scheijen, J. L. J. M., van de Waarenburg, M. P. H., Stehouwer, C. D. A., Wouters, K., & Schalkwijk, C. G. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6289831 · Cited by 22
Self-citation
Development of thiazole-appended novel hydrazones as a new class of α-amylase inhibitors with anticancer assets: an in silico and in vitro approach
Chahal, S., Punia, J., Rani, P., Singh, R., Mayank, M., Kumar, P. P., Kataria, R., Joshi, G., & Sindhu, J. (2023) · RSC Medicinal Chemistry · doi:10.1039/d2md00431c · Cited by 19
Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis
Litwinowicz, K., Waszczuk, E., & Gamian, A. (2021) · Nutrients · doi:10.3390/nu13103370 · Cited by 20
Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression
Wetzels, S., Wouters, K., Miyata, T., Scheijen, J. L. J. M., Hendriks, J. J. A., Schalkwijk, C. G., & Vanmierlo, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051311 · Cited by 17
Self-citation
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems
Wouters, K., Cento, A. S., Gaens, K. H. J., Teunissen, M., Scheijen, J. L. J. M., Barutta, F., Chiazza, F., Collotta, D., Aragno, M., Gruden, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96859-7 · Cited by 15
Self-citation
Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis
Figueroa, K. P., Tapia, G., Cadagan, C., Quezada, N., Torres, J., D’Espessailles, A., & Pettinelli, P. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.005 · Cited by 16
Remodeling of liver phospholipidomic profile in streptozotocin-induced diabetic rats
Simões, C. S. O., Domingues, P. M., Ferreira, R. M., Amado, F. M. L., Duarte, J. A., Vitorino, R. M. P., Neuparth, M. J., Nunes, C., Rocha, C., Duarte, I. F., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.07.029 · Cited by 14
Dietary Glycotoxins Impair Hepatic Lipidemic Profile in Diet-Induced Obese Rats Causing Hepatic Oxidative Stress and Insulin Resistance
Neves, C., Rodrigues, T., Sereno, J., Simões, C. S. O., Castelhano, J., Goncalves, J., Bento, G., Goncalves, S. I., Seiça, R. M. F., Domingues, M. R., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6362910 · Cited by 14
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Michel, M. S., Heß, C., Kaps, L., Kremer, W. M., Hilscher, M., Galle, P. R., Moehler, M. H., Schattenberg, J. M., Wörns, M., Labenz, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00119-7 · Cited by 15
Non‐alcoholic fatty liver and lipid profile status in patients with melasma: A case‐control study
Ghassemi, M., Hosseinchi, S., Seirafianpour, F., Dodangeh, M., & Goodarzi, A. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14014 · Cited by 12
Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults
Jahromi, M. K., Tehrani, A. N., Teymoori, F., Daftari, G., Ahmadirad, H., Saber, N., Salehi‐Sahlabadi, A., Farhadnejad, H., & Mirmiran, P. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01365-8 · Cited by 12
Hormetic modulation of hepatic insulin sensitivity by advanced glycation end products
Fabre, N., Thieme, K., da Silva, K. S., Catanozi, S., Cavaleiro, A. M., Júnior, D. A. C. P., Okamoto, M. M., Morais, M., Falquetto, B., Zorn, T. M. T., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.035 · Cited by 10
Beneficial Effects of Low-Calorie-Carbohydrate/High-Agar Diet on Cardiometabolic Disorders Associated with Non-Alcoholic Fatty Liver Disease in Obese Rats
Louala, S., & Lamri‐Senhadji, M. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.4.400 · Cited by 9
Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients
Shrivastav, D., Singh, D. D., Mir, R., Mehra, P., Mehta, V., & Dabla, P. K. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1754 · Cited by 8
Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease
Lian, K., Feng, Y., Li, R., Liu, H., Peng, H., Zhou, L., Li, C., & Wang, Q. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23148 · Cited by 8
Advanced glycation endproducts produced by in vitro glycation of type I collagen modulate the functional and secretory behavior of dorsal root ganglion cells cultivated in two-dimensional system
Búfalo, M. C., de Almeida, M. E. S., Franca, I. A., Zambelli, V. O., Sant’Anna, M. B., Kimura, L. F., Giardini, A. C., Cury, Y., & Sampaio, S. C. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.020 · Cited by 7
Early AGEing and metabolic diseases: is perinatal exposure to glycotoxins programming for adult-life metabolic syndrome?
Francisco, F. A., Saavedra, L. P. J., Ferreira-Junior, M. D., Barra, C., Matafome, P. N., Mathias, P. C. D. F., & Gomes, R. M. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa074 · Cited by 8
Exogenous H2S reduces oxidative stress induced by lipid mixture in HepG2 cells through USP22/SIRT1 axis
Cui, X., Li, C., He, S., & Li, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-04924-2 · Cited by 6
An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE/NF-kB pathway in mice
Liu, J., Li, H., Chen, H., Xiao, X., Jin, Z., Paerhati, P., Bao, W., Cui, C., Zhu, J., & Yuan, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117737 · Cited by 5
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE
Zaman, A., Arif, Z., Moinuddin, M., Akhtar, K., Ali, W. M., & Alam, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216736 · Cited by 5
Does AGE–RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?
Prasad, K., Khan, A. S., & Bhanumathy, K. K. (2022) · International Journal of Angiology · doi:10.1055/s-0042-1742587 · Cited by 5
Another Player in the Field: Involvement of Glycotoxins and Glycosative Stress in Insulin Secretion and Resistance
Matafome, P. N. (2020) · Diabetology · doi:10.3390/diabetology1010004 · Cited by 5
Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model
Allam, M. M., & Gazzar, W. B. E. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1348362 · Cited by 5
What is the influence of policosanol supplementation on liver enzymes? A systematic review and dose-response meta-analysis of randomized controlled trials
Gholamrezayi, A., Amini, M. R., Rasaei, N., Akhgarjand, C., Kalantar, Z., Askari, G., & Hekmatdoost, A. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103018 · Cited by 4
Alterations in hepatic amino acid metabolism related to MASLD in individuals with obesity
Pérez-Díaz, A. J., Ros‐Madrid, I., Martínez‐Sánchez, M. A., Rico‐Chazarra, S., Oliva‐Bolarín, A., Román, A. B., Fernández-Ruiz, V. E., Martínez, C. M., Yuste, J. E., Ferrer‐Gómez, M., et al. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01086-7 · Cited by 3
Accumulation of Non-Pathological Liver Fat Is Associated with the Loss of Glyoxalase I Activity in Humans
Peter, A., Schleicher, E. D., Kliemank, E., Szendroedi, J., Königsrainer, A., Häring, H., Nawroth, P. P., & Fleming, T. H. (2024) · Metabolites · doi:10.3390/metabo14040209 · Cited by 3
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients
Hyogo, H., Yamagishi, S., Maeda, S., Fukami, K., Ueda, S., Okuda, S., Nakahara, T., Kimura, Y., Ishitobi, T., & Chayama, K. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0223-4 · Cited by 3
Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide‐induced diabetes
Chao, K., Chen, S., Chang, C., Lee, Y., Wang, C., & Chang, J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600753 · Cited by 3
Novel Organic Mineral Complex Prevents High-Fat Diet-Induced Changes in the Gut and Liver of Male Sprague-Dawley Rats
Crawford, M. S., Mohr, A. E., & Sweazea, K. L. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/8846401 · Cited by 3
Metabolic Syndrome and Metabolic Dysfunction‐Associated Fatty Liver Disease
Koo, B. K., & Lim, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch13 · Cited by 3
CIGB-258, a Potential Novel Approach to Treat Sepsis-like Hyperinflammation, Reduces Gastrointestinal Hemorrhage in Zebrafish Exposed to Carboxymethyllysine and Ethanol
Cho, K., Lee, Y., Lee, S. H., Bahuguna, A., Domínguez-Horta, M. D. C., & Martínez‐Donato, G. (2026) · Pharmaceuticals · doi:10.3390/ph19030510 · Cited by 2
Early postnatal exposure of rat pups to methylglyoxal induces oxidative stress, inflammation and dysmetabolism at adulthood
Francisco, F. A., Saavedra, L. P. J., Ferreira-Junior, M. D., Cavalcante, K. V. N., Moreira, V. M., Prates, K. V., Borges, S. C., Buttow, N. C., Ribeiro, T. A., Pedrino, G. R., et al. (2022) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017442100074x · Cited by 2
Associations of dietary advanced glycation end products with liver steatosis via vibration controlled transient elastography in the United States: a nationwide cross-sectional study
Xie, F., Zhao, J., Liu, D., Wan, Z., Sun, K., & Wang, Y. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03253-2 · Cited by 2
Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine
Lee, J., Gu, M. J., Lee, Y. R., Kim, Y., Choi, I., Kim, D., & Ha, S. K. (2024) · Nutrients · doi:10.3390/nu16142330 · Cited by 2
The Role of Glyoxalase-I in Oxidant Stress of Liver Damage
Hollenbach, M., & Zipprich, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803951-9.00007-0 · Cited by 1
Impact of Glyoxalase-I (Glo-I) and Advanced Glycation End Products (AGEs) in Chronic Liver Disease
Hollenbach, M. (2017) · InTech eBooks · doi:10.5772/intechopen.68417 · Cited by 1
The Effects of Dietary Advanced Glycation End Products (AGEs) on Liver Disorders
Agh, F., & Shidfar, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00018-5 · Cited by 1
The analysis of advanced glycation endproducts
Scheijen (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170621js · Cited by 1
Nɛ-(Carboxymethyl)lysine is involved in hepatic steatosis
Greenhill, C. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.179

Authors: Gaens, K. H. J., Niessen, P. M. G., Rensen, S. S., Buurman, W. A., Greve, J. W. M., Driessen, A., Wolfs, M. G. M., Hofker, M. H., Bloemen, J. G., Dejong, C. H., Stehouwer, C. D. A., & Schalkwijk, C. G.
Affiliations: Maastricht University Medical Centre (NL)
University Medical Center Groningen (NL)
Corresponding author: Schalkwijk, Casper G.
ORCID: Rensen, Sander S.
Buurman, Wim A.
Greve, Jan Willem M.
Driessen, Ann
Stehouwer, Coen D.A.
Schalkwijk, Casper G.
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2012-03
Volume: 56
Issue: 3
Pages: 647-655
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2011.07.028
OpenAlex: W1964714465
Cited by: 109
References: 36
Citations by year: 2026: 4 · 2025: 3 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 6 · 2019: 14 · 2018: 10 · 2017: 15 · 2016: 7 · 2015: 8 · 2014: 2 · 2013: 6 · 2012: 3
FWCI: 2.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders: Universiteit Maastricht
Nierstichting (01C-104)
Diabetes Fonds (01C-104)
Maastricht Universitair Medisch Centrum
Center for Translational Molecular Medicine (01 C-104)
Transnationale Universiteit Limburg
SenterNovem
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: carboxymethyllysine, advanced glycation end products, non-alcoholic fatty liver disease, hepatic steatosis, liver inflammation, receptor for advanced glycation end products, lipid peroxidation, inflammatory cytokines, plasminogen activator inhibitor-1, interleukin-8, C-reactive protein, pyridoxamine, aminoguanidine, hepatocyte lipid accumulation, obesity
MeSH terms: Aged, Biopsy, Enzyme Inhibitors, Fatty Liver, Female, Guanidines, Humans, Liver, Lysine, Male, Middle Aged, Obesity, Pyridoxamine, Vitamin B Complex, Biomarkers, Gene Expression, Cytokines, Hepatocytes, Hep G2 Cells, Non-alcoholic Fatty Liver Disease, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks